Confirmed Speakers Include:

Maximizing Bioavailability and Expediting Time-to-Market for Poorly Soluble Drug Candidates

Working off of last year’s tremendous success, the 6th Improving Solubility Conference will provide you with immediate takeways from 3 days of in-depth case studies and discussions of how to effectively improve drug candidate solubility and bioavailability.

Poorly soluble compounds represent over 60% of compounds in drug development and this figure is continuing to increase as technologies become more complex. Learn the latest methodologies and technologies to take on this challenge and minimize the time-to-market on your drug pipeline.

Learn exclusive information from the top leaders in this space who are only sharing information with you. These takeaways include the tools to:

  • Utilize solid dispersion processes during our half-day devoted to amorphous formulation
  • Predict absorption of new chemical entities within silico modeling
  • Utilize Pharmaceutical Co-Crystals to enhance solubility and dissolution of insoluble APIs
  • Maximize the systematic exposure of drugs in toxicology evaluations and early formulation
  • Enhance the bioavailability of poorly soluble compounds using lipid-based formulations
  • Investigate strategies to maintain your patent life-cycle
“With the increasing number of poorly soluble drug candidates entering the preclinical and initial phase of product development, the concepts and applications presented in this conference provide guidance and valuable technical insights for the developmental scientist needed to provide stable and robust formulation platforms in the context of today’s R&D paradigm.”
Alphonso Higuera, PhD, Preformulation PR&D, Forest Research Institute

See how like-minded formulation experts are approaching problems concerning solubility. Those in attendance that you will network with include:

Head, Principal, Senior, Formulation and Research Scientists, Directors, Managers and Researchers specializing in:

  • Formulation and Pre-Formulation
  • Discovery R&D
  • Preclinical Development
  • Analytical Development
  • Drug Delivery
  • Medicinal Chemistry
  • Product Development
  • Toxicology
  • Pharmacokinetics
  • Physiochemistry
  • Solid States
  • Process R&D

Past-Attendees-List View a full list of past attendees here

What past attendees are saying about Improving Solubility conferences:

“Very informative and well presented...learned a lot.”
Principal Scientist, Elan Drug Technologies
“Great job! Exactly what I wanted to learn.”
Scientist II, Pfizer, Inc.
“Very good discussion on the Lipolysis model and lipid forumulation.”
Head of Preforumulation, H. Lundbeck
“Very well organized Master Class. Great attendance and interaction.”
Associate Scientist, Lexicon Pharmaceuticals
“Good sessions - good scientists!!”
Technical Manager Solubilization, BASF
Sponsors
_Sponsors175new
Media Partners
_media175_animated

[ Register Now ]